Tianshan Bio

300313

10.440.19% ( -0.02 )

Delay Closed: Nov 13, 15:00:00

Q3 2026 Earnings

Financial report interval: 2026.06.30 - 2026.09.30

Overview: Tianshan Bio(300313) the Revenue is 113.76 M (+574.5%);the EBIT is 4.969 M (+399.4%);the EPS is 0.0007 (+105.6%).

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

0.11B574.46%

----

----

EBIT

0.00B399.35%

----

----

EPS

0.0007105.55%

----

----

Upcoming earnings report - FY2026 Annual Earning Release

Available dateApr 27, 2027

Estimate Revenue--

Estimate EBIT--

Estimate EPS--

Revenue

ActualEstimateUnit: CNY

Quarterly

EBIT

ActualEstimateUnit: CNY

Quarterly

Net income

ActualEstimateUnit: CNY

Quarterly

EPS

ActualEstimateUnit: CNY

Quarterly